WON TECH CO.,Ltd.
KKRX:3365703,805.00
KRW
-90.00
(-2.31%)
ISIN
KR7336570007
Return %
Stock
S&P 500
1Y
-55.86
14.39
3Y
-58.19
81.42
5Y
42.24
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Jung-hyun Kim
- Full Time Employees
- 250
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 64 Techno 8-ro Daejeon DE South Korea 34012
- IPO Date
- Dec 19, 2019
- Website
- wtlaser.com
- Similar Companies
- Business
- WON TECH Co., Ltd. operates as a South Korean medical laser and energy-based device company specializing in skin aesthetics and medical aesthetic equipment. Its core product portfolio includes picosecond lasers (1064 nm, 532 nm Nd:YAG; 755 nm Alexandrite), RF devices such as OLIGIO and ULTRASKIN TIGHTAN series, high-intensity focused ultrasound (HIFU) devices like ULTRALIPO and ULTRAKING, Q-switched lasers, and long-pulsed Nd:YAG lasers including MERCURY and COSJET SR. The company manufactures advanced aesthetic medical devices incorporating proprietary laser and ultrasonic technologies, supporting skin treatment, anti-aging, fat reduction, and surgical applications. WON TECH’s operations extend internationally, with recent establishment of new European headquarters and joint ventures targeting local production in China. Founded in 2000 and headquartered in South Korea, WON TECH has recently executed strategic operational expansions, including a 2024 joint venture with SBT Ultrasonic Technology Co., Ltd. in China aimed at localizing production and technology transfer for key devices such as Picocare 450 and Pastelle. This JV supports expansion into the Chinese market and broadens medical device R&D efforts. In 2024-2025, WON TECH also authorized an equity buyback program and reported robust financial growth with revenues exceeding KRW 115 billion in 2023 and a significant operating profit. The company continues to enhance its product lineup with innovative launches leveraging its core source laser and ultrasonic technologies and reinforces its global distribution through new regional offices, including in Europe, while focusing on expanding market share in the fast-growing aesthetic device market. WON TECH’s product innovation center and manufacturing capabilities incorporate advanced automated CNC machinery and precision testing, enabling significant production efficiency improvements to meet growing global demand. Its product applications target dermatology clinics, aesthetic centers, and surgical facilities worldwide. The firm holds certifications and awards that support its status as a leader in the medical aesthetic device industry, reflecting ongoing commitments to environment management and technological innovation. WON TECH’s integration of high-end laser light sources and ultrasonic generators defines its strategic differentiation in the competitive medical device sector.